Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26FYA6G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,420
Award facts
- Contract value 100% obligated
- $12,420.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12.4K delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 8, 2026, for the supply of Kesimpta 20 mg/0.4 mL pen injections. This firm fixed-price, non-set-aside contract is scheduled for completion by January 9, 2026, with performance executed from the company's Conshohocken, Pennsylvania location. The delivery order represents a task order issued under a larger Indefinite Delivery Contract vehicle established between the Defense Logistics Agency Troop Support Medical and Cencora, Inc., valued at up to $999.999 million through December 2031.
Kesimpta is a prescription medication used in the treatment of multiple sclerosis, reflecting the Defense Logistics Agency's ongoing procurement of specialty pharmaceutical products to support military healthcare systems and beneficiaries worldwide. Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor within the federal medical supply chain, with an established history of fulfilling competitive federal procurement requirements across multiple therapeutic domains including neurological treatments, diabetes medications, and oncology products. The parent company's substantial $999.999 million IDC with the Defense Logistics Agency demonstrates the contractor's significant role in supplying comprehensive pharmaceutical and medical commodity support to military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FYA6G?
SPE2DR26FYA6G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FYA6G worth?
The government has obligated $12,420 on SPE2DR26FYA6G.
Is contract SPE2DR26FYA6G an order under another contract?
Yes. SPE2DR26FYA6G is a delivery order under SPE2DR25D6044, an indefinite delivery contract.
Was contract SPE2DR26FYA6G competed?
The extent of competition for SPE2DR26FYA6G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award